Your browser is no longer supported. Please, upgrade your browser.
Settings
ADMA ADMA Biologics, Inc. daily Stock Chart
ADMA [NASD]
ADMA Biologics, Inc.
Index- P/E- EPS (ttm)-1.42 Insider Own25.24% Shs Outstand41.97M Perf Week52.35%
Market Cap177.11M Forward P/E- EPS next Y-0.83 Insider Trans0.00% Shs Float29.61M Perf Month24.12%
Income-60.70M PEG- EPS next Q-0.35 Inst Own58.10% Short Float5.91% Perf Quarter-17.42%
Sales24.90M P/S7.11 EPS this Y-19.00% Inst Trans-1.60% Short Ratio4.26 Perf Half Y-28.11%
Book/sh0.80 P/B5.27 EPS next Y40.70% ROA-57.40% Target Price10.50 Perf Year4.98%
Cash/sh- P/C- EPS next 5Y- ROE-159.40% 52W Range2.08 - 6.96 Perf YTD76.57%
Dividend- P/FCF- EPS past 5Y-6.60% ROI-48.60% 52W High-39.37% Beta2.95
Dividend %- Quick Ratio4.90 Sales past 5Y82.70% Gross Margin-72.40% 52W Low102.88% ATR0.34
Employees295 Current Ratio6.30 Sales Q/Q-10.60% Oper. Margin- RSI (14)66.80 Volatility14.43% 10.78%
OptionableYes Debt/Eq1.18 EPS Q/Q44.60% Profit Margin- Rel Volume2.46 Prev Close3.82
ShortableYes LT Debt/Eq1.18 EarningsMar 04 AMC Payout- Avg Volume411.11K Price4.22
Recom1.90 SMA2034.65% SMA5024.26% SMA200-14.45% Volume1,011,871 Change10.47%
Feb-07-19Resumed H.C. Wainwright Buy $10
Dec-11-17Reiterated Maxim Group Buy $13 → $8
Nov-14-17Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17Upgrade Maxim Group Hold → Buy $13
Aug-01-16Downgrade Maxim Group Buy → Hold
Jul-25-16Reiterated Maxim Group Buy $24 → $14
May-13-15Reiterated Maxim Group Buy $18 → $24
Dec-08-14Initiated Oppenheimer Outperform $20
Dec-01-14Reiterated Maxim Group Buy $16 → $18
Feb-12-19 12:30PM  Watch These Tech Stocks Set The Pace On Tuesday 2/12/19 ACCESSWIRE +20.83%
07:38AM  ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors GlobeNewswire
Jan-07-19 07:08AM  ADMA Biologics Submits Response and Provides Supplemental Information to FDA for BIVIGAM® Complete Response Letter GlobeNewswire +6.44%
Dec-26-18 11:40AM  Have Insiders Been Buying ADMA Biologics, Inc. (NASDAQ:ADMA) Shares This Year? Simply Wall St. -9.21%
Dec-23-18 07:25AM  Here is What Hedge Funds Think About ADMA Biologics Inc (ADMA) Insider Monkey
Dec-20-18 06:20PM  Here's Why ADMA Biologics Is Getting Hammered Today Motley Fool -45.61%
06:08AM  ADMA to Host Conference Call to Discuss Recent Regulatory Update on BIVIGAM® PAS Submissions GlobeNewswire
Dec-19-18 06:36PM  FDA declines to approve re-launch of ADMA Biologics' Bivigam Reuters
06:10PM  FDA declines to approve re-launch of ADMA Biologics' Bivigam Reuters
05:58PM  ADMA Biologics Provides Regulatory Update on BIVIGAM® PAS Submissions GlobeNewswire
09:18AM  ADMA Biologics Provides Regulatory Update for BIVIGAM® GlobeNewswire
Dec-17-18 06:30AM  ADMA Biologics Upcoming PDUFA Dates and Milestones ACCESSWIRE
Dec-16-18 02:18PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Nov-13-18 08:10AM  Report: Developing Opportunities within Evelo Biosciences, ADMA Biologics, Karyopharm Therapeutics, Pingtan Marine Enterprise, Rosetta Stone, and Williams Companies Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-08-18 05:27PM  Adma Biologics: 3Q Earnings Snapshot Associated Press
05:05PM  ADMA Biologics Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-30-18 10:00AM  ADMA: Bivigam Delay But Will Recoup Sales Later Zacks Small Cap Research +6.56%
Oct-17-18 07:08AM  ADMA Biologics Receives PDUFA Date for RI-002 GlobeNewswire
Oct-11-18 08:48AM  ADMA Biologics Provides Regulatory Update for BIVIGAM® GlobeNewswire
Oct-03-18 07:08AM  ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center GlobeNewswire
Oct-01-18 07:08AM  ADMA Biologics Resubmits Biologics License Application for RI-002 GlobeNewswire -5.80%
Sep-05-18 07:08AM  ADMA Biologics Reports FDA Compliance Status for its Manufacturing Facility has Improved GlobeNewswire +6.04%
Aug-31-18 02:44PM  Penny Stocks to Watch for September 2018 Investopedia
Aug-27-18 09:15AM  ADMA: FDA Submissions are Next Milestones Zacks Small Cap Research
07:28AM  ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference GlobeNewswire
Aug-10-18 07:18AM  Adma Biologics: 2Q Earnings Snapshot Associated Press
07:08AM  ADMA Biologics Reports Second Quarter 2018 Financial Results GlobeNewswire
Jul-30-18 10:30AM  ADMA: Inspection Concluded; Product Filings Can Begin Zacks Small Cap Research
Jul-27-18 08:44AM  Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter Benzinga
Jul-26-18 03:39PM  Here's Why ADMA Biologics Rose as Much as 27.3% Today Motley Fool +21.46%
10:50AM  ADMA Biologics Reports Successful Close-Out of its April 2018 FDA Compliance Inspection GlobeNewswire
07:58AM  ADMA Biologics Receives PDUFA Date for BIVIGAM® Regulatory Submission GlobeNewswire
Jun-25-18 07:08AM  ADMA Biologics Added to the Russell 3000 and Russell 2000 Indexes GlobeNewswire
Jun-13-18 07:48AM  Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111 Benzinga
Jun-12-18 04:05PM  ADMA Biologics Announces Closing of $40M Public Offering GlobeNewswire
Jun-08-18 09:08AM  ADMA Biologics Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jun-07-18 04:05PM  ADMA Biologics Announces Proposed Public Offering of Common Stock GlobeNewswire
Jun-04-18 10:00AM  ADMA: Biotest Share Retirement Good for Shareholders Zacks Small Cap Research -7.98%
May-18-18 09:47AM  Who Owns Most Of ADMA Biologics Inc (NASDAQ:ADMA)? Simply Wall St.
07:30AM  Blog Exposure - ADMA Biologics Received US Patent for Treating Respiratory Infections ACCESSWIRE
May-16-18 07:30AM  ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections GlobeNewswire
May-14-18 05:28PM  Adma Biologics: 1Q Earnings Snapshot Associated Press +5.41%
05:05PM  ADMA Biologics Reports First Quarter 2018 Financial Results GlobeNewswire
01:17PM  ADMA Biologics Retires Approximately 8.6 Million Shares Previously Issued to Biotest GlobeNewswire
May-08-18 01:55PM  Will ADMA Biologics Incs (NASDAQ:ADMA) Earnings Grow In The Next Couple Of Years? Simply Wall St.
Apr-24-18 07:28AM  ADMA Biologics Announces the Release of its First Commercial Batch of Nabi-HB Manufactured Under its Ownership GlobeNewswire
Mar-19-18 06:30PM  ADMA Biologics Inc (NASDAQ:ADMA): Should The Recent Earnings Drop Worry You? Simply Wall St. +5.75%
Mar-12-18 03:50PM  When Will ADMA Biologics Inc (NASDAQ:ADMA) Turn A Profit? Simply Wall St.
Mar-05-18 07:00AM  ADMA Biologics Reports Full Year 2017 Financial Results GlobeNewswire
Feb-27-18 07:08AM  ADMA Biologics to Present at Raymond James 39th Annual Institutional Investors Conference GlobeNewswire
Jan-29-18 04:32PM  Does ADMA Biologics Incs (NASDAQ:ADMA) CEO Salary Compared Well With Others? Simply Wall St.
Dec-15-17 10:55AM  Does ADMA Biologics Incs (NASDAQ:ADMA) Past Performance Indicate A Weaker Future? Simply Wall St. +6.05%
Dec-13-17 07:50AM  Wired News ADMA Files Biologics License Application for Its Third Plasma Collection Center ACCESSWIRE
Dec-11-17 07:08AM  ADMA Files Biologics License Application For Its Third Plasma Collection Center GlobeNewswire -5.43%
Nov-29-17 10:46AM  ETFs with exposure to ADMA Biologics, Inc. : November 29, 2017 Capital Cube
Nov-27-17 10:10AM  ADMA Biologics Inc (ADMA): What Does It Mean For Your Portfolio? Simply Wall St.
Nov-15-17 08:08AM  ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions GlobeNewswire +11.27%
Nov-13-17 05:00PM  ADMA: Third Quarter 2017 Financial Results and Corporate Update Zacks Small Cap Research +6.90%
12:30PM  ADMA Biologics Announces Closing of $42M Follow-On Offering GlobeNewswire
Nov-10-17 03:35PM  Are ADMA Biologics Incs (ADMA) Interest Costs Too High? Simply Wall St.
Nov-09-17 08:58AM  ADMA Biologics Announces Pricing of Follow-On Offering GlobeNewswire +11.11%
Nov-08-17 02:29PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017 Capital Cube
Nov-07-17 09:34AM  ETFs with exposure to ADMA Biologics, Inc. : November 7, 2017 Capital Cube +8.74%
Nov-03-17 05:08PM  Adma Biologics posts 3Q profit Associated Press
05:02PM  ADMA Biologics Provides Corporate Update and Reports Third Quarter 2017 Financial Results GlobeNewswire
Oct-27-17 04:11PM  Why ADMA Biologics Inc (ADMA) Could Be A Buy Simply Wall St.
Oct-25-17 09:45AM  ETFs with exposure to ADMA Biologics, Inc. : October 25, 2017 Capital Cube
Oct-11-17 07:11AM  Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing GlobeNewswire
Sep-28-17 10:08AM  ETFs with exposure to ADMA Biologics, Inc. : September 28, 2017 Capital Cube -10.70%
Sep-07-17 12:03PM  ETFs with exposure to ADMA Biologics, Inc. : September 7, 2017 Capital Cube
Sep-05-17 11:53AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017 Capital Cube
Aug-28-17 09:00AM  ADMA: Second Quarter 2017 Financial Results and Corporate Update Zacks Small Cap Research
Aug-23-17 07:38AM  ADMA Biologics to Present at Upcoming Investor Conferences GlobeNewswire
Aug-11-17 09:25PM  Adma Biologics reports 2Q loss Associated Press
04:15PM  ADMA Biologics Provides Corporate Update and Reports Second Quarter 2017 Financial Results GlobeNewswire
Jul-31-17 04:15PM  ADMA Biologics Strengthens Patent Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Methods GlobeNewswire
Jul-13-17 03:23PM  ETFs with exposure to ADMA Biologics, Inc. : July 13, 2017 Capital Cube
Jun-27-17 07:08AM  ADMA Biologics Provides Corporate Timeline and Activities Update to Stockholders GlobeNewswire +12.78%
Jun-06-17 03:33PM  ADMA Biologics Completes Acquisition of Biotests Therapy Business Unit Assets GlobeNewswire
Jun-05-17 01:59PM  ETFs with exposure to ADMA Biologics, Inc. : June 5, 2017 Capital Cube
Jun-02-17 10:28AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
May-30-17 07:38AM  ADMA Biologics Stockholders Vote to Approve Acquisition of Certain Assets from Biotest Pharmaceuticals Corporation GlobeNewswire
May-25-17 04:15PM  ADMA Biologics to Present at Jefferies 2017 Healthcare Conference GlobeNewswire
May-19-17 03:00PM  ADMA: 1Q:17 Results and Biotest Acquisition: Valuation Implications Zacks Small Cap Research
May-12-17 04:08PM  Adma Biologics reports 1Q loss Associated Press
04:05PM  ADMA Biologics Provides Corporate Update and Reports First Quarter 2017 Financial Results GlobeNewswire
Apr-20-17 02:10PM  ETFs with exposure to ADMA Biologics, Inc. : April 20, 2017 Capital Cube
Apr-07-17 03:41PM  ETFs with exposure to ADMA Biologics, Inc. : April 7, 2017 Capital Cube
Mar-27-17 05:39PM  Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of ADMA Biologics, Inc. - ADMA PR Newswire
Mar-20-17 09:26AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
09:26AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
Mar-14-17 03:01PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Capital Cube
03:01PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
Mar-02-17 01:04PM  ADMA BIOLOGICS, INC. Financials
Feb-24-17 04:37PM  ADMA Biologics Reports Year End 2016 Financial Results, Accomplishments and Upcoming Milestones GlobeNewswire
04:32PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
Feb-17-17 04:32PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-23-17 04:59PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu
03:24PM  ADMA Biologics upgraded by Maxim Group
07:00AM  ADMA Biologics to Acquire Certain Assets from Biotest Pharmaceuticals Corporation and Become a Vertically Integrated Commercial Plasma Products Company GlobeNewswire
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical trials for the treatment of primary immune deficiency disease. The company also operates source plasma collection facilities in Norcross and Marietta, Georgia. In Addition, the company offers Nabi-HB for the treatment of acute exposure; and Bivigam for the treatment of primary humoral immunodeficiency. It distributes its products through independent distributors, sales agents, specialty pharmacies, and others. The ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grossman Adam SPresident and CEOJun 08Buy4.7852,301249,999796,301Jun 11 07:09 AM
Grossman Adam SPresident and CEOJun 08Buy4.7820,921100,00232,527Jun 11 07:09 AM
Grossman Jerrold BDirectorJun 08Buy4.7831,381150,00131,381Jun 11 07:10 AM
Grossman Jerrold BDirectorJun 08Buy4.7820,921100,00298,007Jun 11 07:10 AM
LENZ BRIANVP, CFOJun 08Buy4.785,00023,90020,000Jun 11 07:08 AM
Guiheen Lawrence P.DirectorJun 08Buy4.7820,00095,60025,000Jun 11 07:09 AM
RICHMAN ERIC IDirectorJun 08Buy4.785,23024,99936,530Jun 11 07:08 AM